Discover
AEMD
Aethlon Medical, Inc.
6.05
2 x 4.74
2 x 8.23
bid
ask
+
0.04
0.67%
2 @ 07:44 PM
6.12 +0.07 (1.16%)
| Ytd | -56.32% | |
| 1y | -83.65% |
6.03
day range
6.18
1.43
52 week range
37.00
| Open | 6.12 | Prev Close | 6.01 | Low | 6.03 | High | 6.18 | Mkt Cap | 9.70M |
| Vol | 15.18K | Avg Vol | 2.56M | EPS | -33.19 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 1.75 | Short Ratio | 0.98 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 3.74 | 200-d Avg | 8.40 | 1yr Est | 3.85 |
| Income Statement | |||
| Operating Expenses | 1.58M | ||
| Selling, General and Administrative Expense | 662.45K | ||
| Operating Income | -1.58M | ||
| Net Income | -1.55M | ||
| Net Income Common Stock | -1.55M | ||
| Net Income Common Stock (USD) | -1.55M | ||
| Consolidated Income | -1.55M | ||
| Earnings per Basic Share | -4.02 | ||
| Earnings per Basic Share (USD) | -4.02 | ||
| Earnings per Diluted Share | -4.02 | ||
| Earning Before Interest & Taxes (EBIT) | -1.55M | ||
| Earning Before Interest & Taxes (USD) | -1.55M | ||
| Weighted Average Shares | 384.71K | ||
| Weighted Average Shares Diluted | 384.71K | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.03M | ||
| Cash and Equivalents (USD) | 5.03M | ||
| Current Assets | 5.61M | ||
| Property, Plant & Equipment Net | 525.31K | ||
| Total Assets | 6.24M | ||
| Debt Current | 255.05K | ||
| Total Debt | 255.05K | ||
| Current Liabilities | 1.04M | ||
| Total Liabilities | 1.04M | ||
| Accumulated Retained Earnings (Deficit) | -176.65M | ||
| Accumulated Other Comprehensive Income | -38.89K | ||
| Shareholders Equity | 5.20M | ||
| Shareholders Equity (USD) | 5.20M | ||
| Assets Non-Current | 624.46K | ||
| Total Debt (USD) | 255.05K | ||
| Trade and Non-Trade Payables | 479.62K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 148.49K | ||
| Net Cash Flow from Financing | 1.82M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -92.66K | ||
| Capital Expenditure | -9.15K | ||
| Issuance (Purchase) of Equity Shares | 1.82M | ||
| Net Cash Flow from Investing | -9.15K | ||
| Net Cash Flow from Operations | -1.90M | ||
| Effect of Exchange Rate Changes on Cash | -4.12K | ||
| Share Based Compensation | 50.00K | ||